Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

ClinicalTrials.gov ID: NCT07035093

Public ClinicalTrials.gov record NCT07035093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 12:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.

Study identification

NCT ID
NCT07035093
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
586 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 29, 2025 (Actual)
Primary completion
Sep 2027 (Estimated)
Completion
Sep 2027 (Estimated)
Last update posted
Sep 25, 2026

2025 – 2027

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
MD First Research - Chandler Chandler Arizona 85286 —
Tucson Orthopaedic Institute - North Wyatt Drive Tucson Arizona 85712 —
Ark Clinical Research - Fountain Valley Fountain Valley California 92708 —
St Joseph Heritage Healthcare Fullerton California 92835 —
Clinical Research Institute Los Angeles California 90048 —
Artemis Institute for Clinical Research San Diego California 92123 —
Alpine Clinical Research Center Boulder Colorado 80301 —
K2 Medical Research - Daytona Beach Daytona Beach Florida 32114 —
Flourish Research - Miami, LLC Miami Florida 33135 —
IMA Clinical Research St. Petersburg St. Petersburg Florida 33704 —
Care Access - Tampa Tampa Florida 33625 —
Charter Research - Lady Lake The Villages Florida 32162 —
Conquest Research Winter Park Florida 32789 —
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 —
Care Access - Lake Charles (Bayou Pines) Lake Charles Louisiana 70601 —
MedVadis Research Corporation Waltham Massachusetts 02451 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
Clinvest Headlands Llc Springfield Missouri 65807 —
Center for Clinical Research Winston-Salem North Carolina 27103 —
Altoona Center For Clinical Research Duncansville Pennsylvania 16635 —
New Phase Research and Development Knoxville Tennessee 37909 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Mercy Family Clinic Dallas Texas 75208 —
Houston Research Institute Houston Texas 77079 —
Sovah Clinical Research-River District Danville Virginia 24541 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07035093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2026 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07035093 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →